triclabendazole has been researched along with Biliary Tract Diseases in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Almeida, T; Gonçalves, Á; Lopes, L; Martins, A; Midões, A | 1 |
Freise, S; Millán, JC; Mull, R; Richter, J | 1 |
Aref, TY; Ismail, Y; Osman, MM | 1 |
De Ronde, T; Dive, C; Lecaillon, JB; Mélange, M; Poltera, AA; Trigaux, JP; Van Beers, B | 1 |
4 other study(ies) available for triclabendazole and Biliary Tract Diseases
Article | Year |
---|---|
Fasciola hepatica-a "Diver" in the Biliary Tree.
Topics: Aged; Animals; Anthelmintics; Benzimidazoles; Biliary Tract; Biliary Tract Diseases; Cholangiopancreatography, Endoscopic Retrograde; Endosonography; Fasciola hepatica; Fascioliasis; Female; Humans; Magnetic Resonance Imaging; Travel-Related Illness; Triclabendazole | 2017 |
Fascioliasis: sonographic abnormalities of the biliary tract and evolution after treatment with triclabendazole.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Anthelmintics; Benzimidazoles; Biliary Tract Diseases; Diagnosis, Differential; Fasciola hepatica; Fascioliasis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Predictive Value of Tests; Triclabendazole; Ultrasonography | 1999 |
Human fasciolosis: a study on the relation of infection intensity and treatment to hepatobiliary affection.
Topics: Adolescent; Adult; Animals; Anthelmintics; Benzimidazoles; Bile Acids and Salts; Biliary Tract Diseases; Child; Fasciola; Fascioliasis; Female; Humans; Liver; Liver Diseases, Parasitic; Male; Triclabendazole | 1999 |
[Distomatosis of the bile ducts. Value of retrograde cholangiography. Efficacy of triclabendazole].
Topics: Aged; Anthelmintics; Benzimidazoles; Biliary Tract Diseases; Cholangiopancreatography, Endoscopic Retrograde; Diagnostic Imaging; Fascioliasis; Humans; Male; Triclabendazole | 1992 |